Skip to main content

Sunscreen

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Pierre Fabre
Pierre FabreFrance - Aignan
1 program
RV4369A cosmetic productN/A1 trial
Active Trials
NCT05837208Completed26Est. Apr 2022
Johnson & Johnson
Johnson & JohnsonNEW BRUNSWICK, NJ
1 program
Sunscreen AN/A1 trial
Active Trials
NCT05565625Completed97Est. Mar 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Pierre FabreRV4369A cosmetic product
Johnson & JohnsonSunscreen A

Clinical Trials (2)

Total enrollment: 123 patients across 2 trials

NCT05837208Pierre FabreRV4369A cosmetic product

Determination of Product Thickness Applied on Different Areas of the Face Using a Multispectral Imaging Method

Start: Apr 2022Est. completion: Apr 202226 patients
N/ACompleted

A Study to Evaluate the Whitening Effect of Mineral Sunscreens in Multi-Cultural Skin Tones

Start: Dec 2021Est. completion: Mar 202297 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.